These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 8578252)

  • 41. Clinical panurothelial disease in patients with superficial bladder tumors: therapeutic implications.
    Solsona E; Iborra I; Ricos JV; Monros JL; Rubio J; Almenar S
    J Urol; 2002 May; 167(5):2007-11. PubMed ID: 11956428
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Current practice compared with the international guidelines: endoscopic surveillance of Barrett's esophagus.
    Amamra N; Touzet S; Colin C; Ponchon T
    J Eval Clin Pract; 2007 Oct; 13(5):789-94. PubMed ID: 17824873
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Bladder cancer: epidemiology, staging and grading, and diagnosis.
    Kirkali Z; Chan T; Manoharan M; Algaba F; Busch C; Cheng L; Kiemeney L; Kriegmair M; Montironi R; Murphy WM; Sesterhenn IA; Tachibana M; Weider J
    Urology; 2005 Dec; 66(6 Suppl 1):4-34. PubMed ID: 16399414
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Evaluation of urine CYFRA 21-1 for the detection of primary and recurrent bladder carcinoma.
    Nisman B; Barak V; Shapiro A; Golijanin D; Peretz T; Pode D
    Cancer; 2002 Jun; 94(11):2914-22. PubMed ID: 12115379
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Tumors of the urinary bladder. Report from a Committee of the Danish Urological society from 1978].
    Ugeskr Laeger; 1982 Apr; 144(15):1063-74. PubMed ID: 7101558
    [No Abstract]   [Full Text] [Related]  

  • 46. European Association of Urology and American Urological Association/Society of Urologic Oncology Guidelines on Risk Categories for Non-muscle-invasive Bladder Cancer May Lead to Overtreatment for Low-grade Ta Bladder Tumors.
    Klaassen Z; Soloway MS
    Urology; 2017 Jul; 105():14-17. PubMed ID: 28366700
    [No Abstract]   [Full Text] [Related]  

  • 47. [Treatment of bladder tumors by "Amsterdam Team on Urological Tumors"].
    Scholtmeijer RJ; Donner R; Thierie AH
    Ned Tijdschr Geneeskd; 1976 Jan; 120(3):83-7. PubMed ID: 1246362
    [No Abstract]   [Full Text] [Related]  

  • 48. Transabdominal ultrasound surveillance for bladder cancer.
    Malone PR
    Urol Clin North Am; 1989 Nov; 16(4):823-7. PubMed ID: 2683311
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Classification of bladder tumors and treatment of superficial infiltrating tumors].
    Donker PJ
    Ned Tijdschr Geneeskd; 1969 Dec; 113(51):2302-4. PubMed ID: 5362037
    [No Abstract]   [Full Text] [Related]  

  • 50. [How are the bladder tumors registered actually?].
    Storm HH
    Ugeskr Laeger; 1995 Nov; 157(45):6279-80. PubMed ID: 7491725
    [No Abstract]   [Full Text] [Related]  

  • 51. [Registration of bladder tumors--the bath-water and the child].
    Clemmesen J
    Ugeskr Laeger; 1995 Oct; 157(43):5996-7. PubMed ID: 7483082
    [No Abstract]   [Full Text] [Related]  

  • 52. [Further experiences in the treatment of epithelial bladder tumors].
    Tjabbes D
    Ned Tijdschr Geneeskd; 1973 Mar; 117(10):421-2. PubMed ID: 4688749
    [No Abstract]   [Full Text] [Related]  

  • 53. [Urinary bladder cancer].
    Jakobsen B; Sell A
    Ugeskr Laeger; 1971 Dec; 133(48):2378-9. PubMed ID: 5135122
    [No Abstract]   [Full Text] [Related]  

  • 54. [Treatment of bladder tumors at a county hospital--a proposal for a care program].
    Berge T; Hedenberg I
    Lakartidningen; 1980 Oct; 77(43):3877-80. PubMed ID: 7453368
    [No Abstract]   [Full Text] [Related]  

  • 55. Essential content of evidence-based clinical practice guidelines for bladder cancer: The Japanese Urological Association 2015 update.
    Kubota Y; Nakaigawa N;
    Int J Urol; 2016 Aug; 23(8):640-5. PubMed ID: 27374472
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Phase II trials in Ta, T1 bladder cancer. The marker tumour concept.
    van der Meijden AP; Hall RR; Kurth KH; Bouffioux C; Sylvester R
    Br J Urol; 1996 May; 77(5):634-7. PubMed ID: 8689102
    [No Abstract]   [Full Text] [Related]  

  • 57. The contribution of pathological anatomy in the procedure to follow in tumors of the bladder.
    Chomé J
    Bull Mem Soc Chir Paris; 1966 Apr; 56(2):87-95. PubMed ID: 5944650
    [No Abstract]   [Full Text] [Related]  

  • 58. [Prospective bladder neoplasm projects].
    Hvidt V
    Ugeskr Laeger; 1972 Sep; 134(36):1914-5. PubMed ID: 5075002
    [No Abstract]   [Full Text] [Related]  

  • 59. [Problem of malignant course of benign tumors of the urinary bladder].
    GEKHMAN BS
    Khirurgiia (Mosk); 1953 Sep; 9():66-7. PubMed ID: 13131512
    [No Abstract]   [Full Text] [Related]  

  • 60. Bladder cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up.
    Moschini M; Gandaglia G; Dehò F; Salonia A; Briganti A; Montorsi F
    Ann Oncol; 2022 May; 33(5):561. PubMed ID: 35121006
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.